A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells

A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells

We have previously demonstrated that DT-010, a novel conjugate of danshensu (DSS) and tetramethylpyrazine (TMP), displays anti-tumor effects in breast cancer cells both in vitro and in vivo. In the present study, we investigated whether DT-010 enhances the chemotherapeutic effect of doxorubicin (Dox...

Full description

Bibliographic Details
Main Authors: Wang, Liang, Chan, Judy Y., Zhou, Xinhua, Cui, Guozhen, Yan, Zhixiang, Wang, Li, Yan, Ru, Di, Lijun, Wang, Yuqiang, Hoi, Maggie P., Shan, Luchen, Lee, Simon M.
Format: Online
Language:English
Published: Frontiers Media S.A. 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979254/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979254/

Similar Items